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Mucormycosis is a rare, fulminant, rapidly spreading fungal infection, which usually affects patient with under-
lying immune deficiency. If not managed promptly, the disease is characterized by progressive necrosis and is 
often fatal. A review of English literature shows that only fourteen cases of mucormycosis have been reported after 
tooth extraction. This paper highlights two cases of mucormycosis subsequent to tooth extraction in healthy adult 
patients. This first patient presented with an oroantral fistula and extensive maxillary necrosis. Whereas the second 
case was localized and presented as non-healing extraction socket with alveolar necrosis. This adds two more cases 
of this rare and serious complication of tooth extraction, to the present literature.




Mucormycosis is a rare opportunistic infection invariably 
affecting immunocompromised patients. The organism 
implicated to cause mucormycosis is a saprophytic fungus, 
mainly rhizopus or mucor.  It is the most deadly and rapidly 
progressive form of fungal infection affecting humans (1).
Clinical presentation of mucormycosis depends upon 
the site of entry of micro-organism and the organ sys-
tems involved. The most common form includes rhi-
nocerebral, which involve the nose, paranasal sinuses, 
orbits and central nervous system. Other forms of mu-
cormycosis are cutaneous, gastrointestinal, pulmonary 
and disseminated (2). Oral mucormycosis is usually cau-
sed by inhalation of spores or direct contamination of 
open oral wound.  Oral mucormycosis affecting immu-
nocompromised patients, mainly diabetes mellitus has 
been reported in literature (3). However those occurring 
subsequent to tooth extraction are rare (4). In view of 
the serious and potentially fatal complication of tooth 
extraction, this paper reports two such cases of mucor-
mycosis presenting as oroantral fistula and non-healing 
extraction socket respectively, in healthy adult patients. 
The findings of the present cases are correlated with pre-
viously reported cases in English literature. 
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A 52 years old male patient, farm labourer by occupation 
presented with complaint of escape of fluid from nose 
after taking liquids and foul smell from mouth since past 
one week. Patient gave history of multiple teeth extrac-
tion one month earlier at a local private clinic.  No con-
tributory medical and family history was reported. In-
traoral examination revealed an area of dehiscence over 
left maxillary alveolus with an oroantral fistula (Fig. 1a). 
Fig. 1: [Case 1] (Clinical presentation of the disease as oroantral 
fistula (a); Water’s view radiograph showing involvement of left 
maxillary sinus (b). Photomicrograph (H & E stained section; 40X 
magnification) showing broad and aseptate fungal hyphae with area 
of necrosed bone (c).
Escape of water from left nostril after oral intake was 
demonstrated clinically. The left maxillary premolars 
and 1st molar were missing, confirming the history of 
previous extraction. Water’s view radiograph was advi-
sed to study the maxilla and the maxillary antrum. The 
radiograph showed destruction of left maxillary bone 
extending superiorly to the infraorbital rim and latera-
lly to the zygomatic bone. Areas of radiopacity were 
evident within the left maxillary antrum, suggestive of 
sequestrum (Fig. 1b). Based on the clinical and radiolo-
gical findings the diagnosis of maxillary osteomyelitis 
causing oroantral fistula was given. Gingival and bone 
incision biopsies were taken for histopathological study. 
The microscopic evaluation revealed broad and aseptate 
fungal hyphae within the area of necrosed bone (Fig. 1c). 
Based on the findings, a final diagnosis of maxillary os-
teonecrosis secondary to mucormycosis was established. 
Patient was recalled for hospitalization and intravenous 
antifungal therapy (amphotericin B; 0.8mg/kg/day for 
4 weeks) was immediately started after serum urea and 
creatinine levels were found to be within normal range. 
Routine blood investigations, including serum glucose 
and complete haemogram showed no deranged values. 
Laboratory examination revealed no underlying immune 
deficiency.
The patient was subjected to computed tomography 
(CT) scan in order to study the extent and location of 
disease. Sectional views of CT scan showed thickening 
of left maxillary antrum lining, with destruction of ante-
rior maxillary wall (Fig. 2a). Three dimensional forma-
Fig. 2: [Case 1] CT scan (axial section) showing thickening of antral 
lining and destruction of anterior wall of maxilla (a); Three dimen-
sional formatted CT image showing involvement of left maxilla (b). 
Intraoperative pictures showing surgical debridement and removal 
of the sequestrum with the buccal fat pad mobilized into the defect 
(arrow) (c); closure of the oroantral communication (d).
tted CT image showed destruction of anterior maxillary 
wall extending antero-posteriorly from the lateral nasal 
wall to the zygomatic bone and supero-inferiorly from 
the maxillary alveolus to just below the infraorbital rim. 
Area of loose bone was seen within the lesion suggestive 
of bony sequestrum (Fig. 2b).
Patient was prepared for surgical debridement and se-
questrectomy along with closure of oroantral fistula, 
under general anesthesia. A written informed consent 
was taken for the same. Buccal mucoperiosteal flap was 
raised after excision of the fistula lining. The maxillary 
bone was exposed and the sequestrum removed. Debri-
dement of maxillary antrum was done to remove the in-
flamed sinus lining, followed by copious irrigation with 
antiseptic solution. Pedicled buccal fat pad was mobi-
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lized by blunt dissection and used to close the defect 
posteriorly. The buccal mucoperiosteal flap was then 
advanced palatally over the buccal fat pad to attain two 
layered closure of oroantral communication (Fig. 2c,d). 
The patient showed uneventful recovery and was kept 
on regular recall visits. At 6 months follow-up patient 
did not show any further progression of the disease.
Case Report 2:
A 37 years old male patient reported to our clinic with 
complaint of pain over upper right posterior region of 
jaw since past 2 weeks. Patient gave history of extrac-
tion of right upper right molars about six weeks back at 
a private dental clinic. The extraction was non-traumatic 
and the immediate post-extraction period was unevent-
ful. No contributory medical and family history was re-
ported. Intraoral examination showed dehiscence of mu-
cosa over right maxillary alveolus. The crestal alveolar 
bone was exposed and appeared yellowish-white with no 
bleeding on probing (Fig. 3a). Orthopantomogram was 
advised, which showed missing mandibular right poste-
Fig. 3: Case 2] Clinical presentation as necrosed alveolar bone at site 
of extraction (a); Orthopantamogram showing of the involved region 
(b). Intra-operative photograph showing closure of the surgical site 
after removal of the necrosed alveolar bone (inset image) (c). Photo-
micrograph (H & E stained section; 100X magnification) showing 
aseptate, thin walled fungal hyphae with irregular contour (d).
rior teeth, with empty extraction sockets, indicative of 
recent extraction. The floor of the right maxillary sinus, 
in-relation to the apical aspect of the extraction sockets 
could not appreciated (Fig. 3b). Routine blood investiga-
tions were within normal limit. No underlying immune 
deficiency was evident on laboratory examination. Pa-
tient was prescribed oral antibiotics (Tablet Amocicillin 
500mg + Potassium Clavulanate 125 two times a day) 
and nasal decongestant. Excision of the necrosed alveo-
lar bone with closure of the defect with buccal advance-
ment flap was planned and executed under local anes-
thesia (Fig. 3c). A written informed consent was taken 
for the same. The excised specimen was submitted for 
histopathological evaluation. Microscopic study of the 
necrotic alveolar bone showed presence of broad asep-
tate, thin walled fungal hyphae (Fig. 3d). Based on the 
presentation and histological findings, diagnosis of oral 
mucormycosis subsequent to tooth extraction was given. 
Patient was admitted and put on intravenous antifungal 
therapy (amphotericin B; 0.8mg/kg/day for 3 weeks). 
Periodic monitoring of serum urea, creatinine and re-
nal function test were done, during antifungal therapy. 
There was no further progression of the disease and on 
four month follow-up visit patient showed satisfactory 
healing. 
Discussion
Mucormycosis is a rare opportunistic fungal infection 
caused by mucorales. It was first reported in humans by 
Paultaufin in 1885 (2). It is also known as zygomyco-
sis or phycomycosis. Three common genera of mucora-
le which cause this disease in human include rhizopus, 
rhizomucor and absidia. Rhizopus accounts for 90% of 
cases involving head and neck region. These fungi exist 
in natural environment including soil, air, food, compo-
site piles, and animal excreta and play role in decompo-
sition. These fungal spores may be inhaled, ingested or 
may enter human body through open wound.  Mucorales 
have been cultured from the oral cavity, nasal passage 
and pharynx of healthy individuals without any clini-
cal signs of infection. Invariably this disease manifests, 
when the organisms affect an immunocompromised pa-
tients. 
Angioinvasion of mucorales and its spores into the blood 
vessels lead to the formation of thrombus, which causes 
progressive necrosis of associated hard and soft tissues. 
The most common form of this disease in maxillofacial 
region is rhinocerebral mucormycosis, with widespread 
involvement of oral cavity, maxilla, palate, nose, para-
nasal sinuses, orbits and central nervous system.  Early 
symptoms of this disease include facial cellulitis, perior-
bital edema and nasal inflammation, followed by wi-
despread tissue necrosis. Failure of prompt medical and 
surgical intervention may lead to cerebral spread, caver-
nous sinus thrombosis, septicemia and multiple organ 
failure lending to high morbidity and mortality (3). The 
cases reported in this paper presented with a localized 
form of oral mucormycosis affecting immunocompetent 
patients, after tooth extraction. 
Search of English literature from PubMed database, 
using combination of terms; mucormycosis, zygomyco-
sis, extraction, exodontia, and maxillary necrosis revea-
led 34 titles, of which only eight cases were reported to 
be associated with tooth extraction. References of these 
papers were further scrutinized and additional five titles 
were identified.  In total 13 papers (total of 14 cases) 
on mucormycosis secondary to tooth extraction were 
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reviewed for demographic details, clinical presentation, 
extent of involvement, treatment provided and outcome 
(Table 1, 1 continue) (4-16). These cases were reported 
from all over the world, with 7 cases (50%) from India 
and 2 cases (14%) from USA. This unique distribution 
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Table 1: Review of previously reported cases of mucormycosis after tooth extraction.
across the globe involving both developed and develo-
ping countries can be explained by relative lack of me-
dical health care facility and more number of immuno-
compromised patients in developing countries like India. 
Whereas reports from developed country like USA can 
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DM – Diabetes Mellitus, Fa - Fatal, F - Female, FESS - functional endoscopic sinus surgery, HBO - Hyperbaric Oxygen , IVAB - Intravenous 
amphotericin B , M - Male, NA - Data not available , NIC- Non immuno-compromised , Sh - Satisfactory healing.
Table 1 continue: Review of previously reported cases of mucormycosis after tooth extraction.
possibly be attributed to presence of multiethnic popu-
lation (17). In this review, males were more commonly 
affected than females (in ratio of 13:5).  While age of pa-
tient ranged from 14 to 74 years (mean of 52.21 years). 
The underlying condition predisposing this fungal infec-
tion included diabetes mellitus (8 cases), leukemia on 
chemotherapy (1 case), chronic obstructive pulmonary 
disease treated with steroid therapy (1 case) and diabe-
tes mellitus along with leukemia (1 case).  This finding 
was consistent with the fact that mucormycosis affect 
patients with compromised immunity. According to lite-
rature, 40-50% of patients suffering from mucormycosis 
have diabetes mellitus as a predisposing factor (3). Aci-
dosis in diabetes mellitus compromises the phagocytic 
ability of white blood cells thereby affecting the host 
immunity. Interestingly among the cases reviewed in 
this paper, three were reported in patients with no immu-
nocompromised condition (10,11,15). This finding was 
consistent with our cases. According to Mignogna M.D. 
et al. (17), mucormycosis affecting healthy individuals 
can be due to the role of local factors in pathogenesis of 
this disease.  Local factors like surgical trauma from too-
th extraction may compromise the local vascularity, as 
well as provide a portal of entry to the microorganisms. 
Tooth decay with periapical infection or periodontitis, 
which invariably are the most common cause of tooth 
removal, may further lower the local host defense me-
chanism.  In the present review, extraction of maxillary 
posterior teeth was most commonly associated with this 
disease, accounting for 85% of all cases. While extrac-
tion of maxillary anterior teeth contributed for one case 
and mandibular molar for two cases (6,13). High pro-
pensity of association of mucormycosis with extraction 
of maxillary posterior teeth can possibly be due to their 
proximity to the maxillary sinus, which often get invol-
ved when fungal spores are inhaled through nasal route. 
Clinical features of the reviewed case included, 
non-healing extraction site (5,6,7,8,14,15,16), edema 
of face (4,12), alveolar bone necrosis with palatal ulcer 
(5,9,12,13), nasal discharge/blockage (5,6,7,10,13), pa-
resthesia of lower lip (6), facial paresthesia (15), trismus 
(15) and headache (7). Further spread of infection result 
in orbital involvement, causing chemosis (edema of con-
junctiva), epiphora (excessive watering of eye), diplopia 
(double/blur vision), ptosis (drooping of upper eyelid), 
proptosis (protrusion of eye ball), ophthalmoplegia (pa-
ralysis of eye muscles), and vision loss (4,8,12,14). As 
the disease is rapidly progressive, imaging modalities 
like computed tomography and magnetic resonance ima-
ging are useful tools to study the extent of necrosis, pa-
ranasal sinuses involvement, orbital and cerebral spread. 
In the present review, majority of the cases showed ex-
tensive involvement of maxillofacial skeleton (71% of 
cases). However, the cases presented, along with three 
of the reviewed cases manifested as localized disease in-
volving only the maxillary alveolar bone and maxillary 
sinus (7,11,13), whereas one case was localized only to 
mandibular alveolus (6). 
Mucormycosis require prompt management to prevent 
further spread and avoid fatal complications. Treatment 
includes immediate hospitalization and systemic anti-
fungal therapy. Amphotericin B is the drug of choice in 
mucormycosis. Supportive therapy includes; fluid ba-
lance, nutritional supplements and correction of under-
lying immune deficiency. Surgical intervention is often 
required to remove the necrosed tissue. In the present 
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review, surgical management included combination of 
one or more procedures like tissue debridement, maxi-
llectomy, sinus exploration and curettage. Functional 
endoscopic sinus surgery and hyperbaric oxygen thera-
py has also been reported for treatment of mucormyco-
sis (6,15). The cases presented were managed by local 
debridement and sequestrectomy. Oroantral fistula in 
the first case was closed using double layered pedicled 
buccal fat pad and buccal advancement flap.  The outco-
me of management of mucormycosis often depends on 
immune status of individual, extent of spread, cerebral 
involvement and systemic dissemination. The review of 
cases showed satisfactory result in 11 cases (79%), whe-
reas three patients (21%) showed fatal outcome. Early 
diagnosis and intervention reduces the extent of spread 
and limits the risk of serious complications. 
Conclusions
Mucormycosis is a rare fungal infection which can cause 
widespread necrosis of orofacial tissues in susceptible 
host. Though incidence of mucormycosis secondary 
to tooth extraction is extremely low, however when it 
occurs, may cause significant morbidity and mortality. 
Hence dental professionals must be aware of the possibi-
lity of this serious and fatal complication, so as to avoid 
unfavorable outcome in clinical practice.
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